Smoking Cessation Interventions for Quitting Smoking
Trial Summary
What is the purpose of this trial?
This project will evaluate a proactive outreach intervention for tobacco cessation among primary care BIPOC populations who smoke in two health systems across the region. Compared with Whites, BIPOC populations in the US experience disproportionate health consequences from commercial cigarette use. Few evidence-based cessation treatments (EBCTs) have been specifically developed, evaluated, or implemented for BIPOC populations. Moreover, uptake of EBCT (e.g. medication, counseling) is lower among BIPOC populations. Reasons for the failure to engage BIPOC patients in EBCTs are complex and multi-level (e.g., patient, provider, healthcare system). To address these gaps, the investigators will assess the added effectiveness of an approach to augment the standard of care with longitudinal proactive outreach to connect BIPOC adults with EBCT. The proposed multi-level intervention leverages the electronic health record to identify patients who smoke, who can then be proactively engaged via culturally tailored outreach to connect them to EBCT. The proactive approach may circumvent experiences of bias within the healthcare system and thus enhance engagement.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Ask-Advice-Connect (AAC) for quitting smoking?
The Ask-Advice-Connect (AAC) method showed a 12.5% smoking cessation rate in a workplace program, which is above the national average, indicating its potential effectiveness. Additionally, proactive outreach strategies, like AAC, can increase access to tobacco treatment and improve quit rates by encouraging attempts among less motivated individuals.12345
Is the Ask-Advice-Connect (AAC) method safe for humans?
The Ask-Advice-Connect (AAC) method is generally considered safe for humans as it involves counseling and connecting individuals to quitlines for tobacco cessation, which are standard practices in healthcare settings. There are no reports of adverse effects related to the AAC method in the available research.12456
How is the Ask-Advice-Connect (AAC) treatment for smoking cessation different from other treatments?
The Ask-Advice-Connect (AAC) treatment is unique because it involves proactive outreach, connecting individuals directly to a quitline, which is a phone-based support service, as part of a workplace cessation program. This approach is different from traditional methods that rely on individuals to seek help themselves, and it has shown higher success rates in encouraging people to quit smoking.12457
Research Team
Steven Fu, MD, MSCE
Principal Investigator
Minneapolis Veterans Affairs Medical Center
Eligibility Criteria
This trial is for BIPOC individuals who are part of the Hennepin Healthcare or MCHS system, speak English or Spanish, currently smoke cigarettes, and want to quit. They must have contact information in their health record. People with cognitive impairments or under legal guardianship, or those who've opted out of research can't participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive AAC plus an MI tailored outreach call at baseline and at 3, 6, and 9 months post-enrollment, with enhanced access to State Quitline and Nicotine Replacement Therapy
Follow-up
Participants are monitored for smoking abstinence and quality of life changes
Treatment Details
Interventions
- Ask-Advice-Connect (AAC)
- Longitudinal Proactive Outreach (LPO)
Ask-Advice-Connect (AAC) is already approved in United States for the following indications:
- Tobacco cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor